← Browse by Condition
Medical Condition

recurrent transformed non hodgkin lymphoma

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT05873712 Phase 2
Recruiting

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

Enrollment
24 pts
Location
United States
Sponsor
Aseel Alsouqi
View Trial →
NCT05432635 Phase 1
Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Enrollment
15 pts
Location
United States
Sponsor
City of Hope Medical Center
View Trial →